This $149,893.46 firm fixed-price purchase order contract was awarded by the U.S. Department of Health and Human Services Centers for Disease Control and Prevention to the Baker Heart and Diabetes Institute, a non-profit research organization, to conduct research on trends in the incidence of young onset Type 2 diabetes. The contract, which did not have a set-aside designation, was completed in February 2019. In addition to this prime contract, Baker Institute has also frequently served as a...
This federal contract award from the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) was made to the Baker Heart And Diabetes Institute, doing business as Baker Institute, a non-profit medical research organization. The $119,000.00 fixed-price purchase order was for research on trends in the incidence of young onset Type 2 diabetes, with a completion date of August 1, 2022. The contract did not utilize a set-aside designation. While Baker Institute has...
The Department of Health and Human Services, Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to the German non-profit organization Deutsche Diabetes Forschungsgesellschaft E.V. for a $146,715.00 diabetes research project. The contract, which had no set-aside designation, funds mathematical modeling and analysis services to forecast diabetes prevalence and assess the impact of risk factors, including the effect of the COVID-19 pandemic. This award is part of...
The Department of Health and Human Services, Centers for Disease Control and Prevention (CDC) awarded a $220,266.39 firm fixed price purchase order contract to Deutsche Diabetes Forschungsgesellschaft E.V, a German non-profit organization, to conduct a diabetes study within U.S. adults. The contract, which does not have a set-aside designation, funds mathematical modeling and risk score analysis to forecast diabetes prevalence and assess the impact of various risk factors, including the...
This federal contract award, valued at $85,272.00, was issued by the Centers for Disease Control and Prevention (CDC) to Deutsche Diabetes Forschungsgesellschaft E.V., a German non-profit organization. The contract is for research services related to "TRUE DIABETES INCIDENCE AND DETECTION IN THE U.S. ADULT PUPLATION." This appears to be a prime contract with no set-aside designation. The services provided include compartment modeling, risk score analysis, and projections on the...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Deutsche Diabetes Forschungsgesellschaft E.V., a German non-profit organization. The contract, valued at $196,324.31, is for the application of compartment models to forecast diabetes prevalence and assess the impact of various risk factors, including the effect of the COVID-19 pandemic. The contract has a period of performance ending on...
This $180,000.00 firm fixed-price purchase order was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency under the U.S. Department of Health and Human Services, to Joslin Diabetes Center, Inc., a non-profit organization based in Boston, Massachusetts. The contract does not have a set-aside designation. The purpose of this award is to provide specialized research-related services and materials to support NIDDK's diabetes studies. Joslin...
This federal contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Deutsche Diabetes Forschungsgesellschaft E.V., a German non-profit organization, to provide research and modeling services related to the prevalence of late diabetes in Pima Indians in the United States. The contract is a firm fixed-price purchase order with a potential value of $147,876.39 and a completion date of September 29, 2018. Deutsche Diabetes...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $249,973.00 firm fixed price purchase order contract to the Research Triangle Institute (RTI International), a nonprofit research organization, to develop a "State Diabetes Health Burden Toolkit". The contract has a completion date of June 30, 2024 and was awarded on August 15, 2022. No set-aside designation was used for this contract. RTI International has a history of supporting various federal agencies through...
This is a firm fixed price BPA call order awarded by the Centers for Disease Control and Prevention (CDC) to Research Triangle Institute (RTI) International, a nonprofit research organization. The $460,186 contract is for the development of a diabetes voice-activated personal assistant and is part of the broader "Achieving Public Health Impact Through Research (APHITR)" BPA vehicle. There is no set-aside designation for this award. RTI, which holds several federal indefinite delivery...